Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays, respectively. Phase 2.

June 21, 2017

prudect name : Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT in cell-free assays, respectively. Phase 2.
Rociletinib (CO-1686, AVL-301)

Synonyms: CAS NO: 1374640-70-6Molecular Formula: C₂₇H₂₈F₃N₇O₃Molecular Weight: 555.55Purity: 98% minSolubility: In DMSOStorage: -20 oC

web site: www.medchemexpress.com